Chronic pancreatitis is a common inflammatory disease of the pancreas. Mutations in the genes encoding cationic trypsinogen (
PRSS1)
1 and the pancreatic secretory trypsin inhibitor (
SPINK1)
2 are associated with chronic pancreatitis. Because increased proteolytic activity owing to mutated
PRSS1 enhances the risk for chronic pancreatitis, mutations in the gene encoding anionic trypsinogen (
PRSS2) may also predispose to disease. Here we analyzed
PRSS2 in individuals with chronic pancreatitis and controls and found, to our surprise, that a variant of codon 191 (G191R) is overrepresented in control subjects: G191R was present in 220/6,459 (3.4%) controls but in only 32/2,466 (1.3%) affected individuals (odds ratio 0.37;
P = 1.1 × 10
−8). Upon activation by enterokinase or trypsin, purified recombinant G191R protein showed a complete loss of trypsin activity owing to the introduction of a new tryptic cleavage site that renders the enzyme hypersensitive to autocatalytic proteolysis. In conclusion, the G191R variant of PRSS2 mitigates intrapancreatic trypsin activity and thereby protects against chronic pancreatitis.